Lincoln National Corp Eye Point Pharmaceuticals, Inc. Transaction History

Lincoln National Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$2.37 - $7.2 $51,606 - $156,780	-21,775 Reduced 55.79%	17,255 $60,000
Q2 2022 Aug 02, 2022	SELL	$7.25 - $12.71 $1,595 - $2,796	-220 Reduced 0.56%	39,030 $307,000
Q4 2021 Jan 26, 2022	BUY	$10.18 - $18.4 $131,831 - $238,279	12,950 Added 49.24%	39,250 $480,000
Q3 2021 Nov 05, 2021	BUY	$7.51 - $11.72 $197,513 - $308,236	26,300 New	26,300 $274,000

176

53.9M

764K

1.57M

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $296M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.